Biotechnology, pharmaceutics and medical technology cooperation trip to Beijing, Guangzhou and Shenzhen from 14 – 21 May 2011
Following the very successful biotech trip in 2010, the Federal Ministry of Economics and Technology and Germany Trade & Invest (GTAI) have asked Brücke Osteuropa (the German Association for Economic and Technological Cooperation with Eastern Europe and Asia) and BIO Deutschland (the German biotechnology industry association) to organise a second cooperation trip to China for this sector.
This trip will take place from 14 to 21 May 2011 as part of the Federal Economics Ministry’s programme of information and networking trips. It is aimed at companies and institutes in the biotechnology, pharmaceutics and medical technology sectors. The focus will be on opportunities for economic and technological cooperation with the biotechnology industry bases in Beijing and in Guangzhou and Shenzhen in the southern Chinese province of Guangdong. The programme will include a German-Chinese cooperation meeting and visits to companies and institutes.
As the cooperation trip will coincide with the trade fair CECIA China Exhibition & Conference on Instrumental Analysis & Biotechnology (www.chinacecia.com/en), which will be held in Guangzhou from 16 to 18 May, the programme will also include a visit to the fair.
Companies and research institutes that are active in biotechnology and its many applications, particularly environmental protection, pharmaceutics and medical technology, are invited to join the delegation. Other related sectors, especially equipment manufacturing, measuring and laboratory technology, bioinformatics and similar fields, are also very welcome.
The participation fee of €2,120 includes the costs of the visa, return economy class flights with Air China from Munich to Beijing, train tickets to Munich, domestic flights within China, accommodation and participation in all of the elements contained in the programme. The fee does not include separate flights to Munich or travel insurance.
You will find further information at www.eastbridge.de/Biotech-China-2011/